Alignment Healthcare (NASDAQ:ALHC) CEO John Kao Sells 215,701 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John Kao sold 215,701 shares of the firm’s stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $20.63, for a total transaction of $4,449,911.63. Following the sale, the chief executive officer owned 1,888,940 shares in the company, valued at approximately $38,968,832.20. The trade was a 10.25% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Stock Performance

Shares of NASDAQ ALHC opened at $20.98 on Tuesday. The stock has a market cap of $4.29 billion, a PE ratio of -2,095.90, a price-to-earnings-growth ratio of 3.00 and a beta of 1.20. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The firm has a fifty day moving average price of $19.26 and a 200-day moving average price of $19.07. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.10. The company had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. Alignment Healthcare’s revenue for the quarter was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.16) EPS. Equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently bought and sold shares of ALHC. Wellington Management Group LLP grew its stake in shares of Alignment Healthcare by 167.3% in the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock worth $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Invesco Ltd. raised its position in shares of Alignment Healthcare by 122.3% during the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after buying an additional 2,294,739 shares in the last quarter. Capital World Investors bought a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $44,203,000. Loomis Sayles & Co. L P bought a new stake in Alignment Healthcare in the fourth quarter worth $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new stake in shares of Alignment Healthcare in the 4th quarter worth about $39,500,000. Institutional investors own 86.19% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ALHC shares. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research report on Friday, January 30th. TD Cowen boosted their price target on Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday, January 16th. Wall Street Zen downgraded Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, March 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. Finally, UBS Group boosted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 14th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Alignment Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $24.75.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.